MedTrace Logo

Relationship Between Serum N/OFQ and Brain-heart Syndrome

NCT05344794 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2023-02-21

No results posted yet for this study

Summary

Choosing the neurology patients in the Second Hospital of Shanxi Medical University, diagnosed with patients with cerebral syndrome into the experimental group; patients who did not have cerebral syndrome included in the control group, and all selected people had no intimate relationship with each other.Specimen collecting control group and the study group serum inflammatory factor IL-6, solvent peptide and catecholamine content. The difference between the two groups of data was observed.According to the literature, it is guess: The solitary peptide content of the experimental group will be higher than the control group, and is positively correlated with IL-6, catecholamine content.The difference was statistically significant.

Conditions

  • Cerebral-Cardiac Syndrome

Interventions

DIAGNOSTIC_TEST

Enzyme-linked immunosorbent assay

Serum N/OFQ , IL-6 and NE levels were detected.

Sponsors & Collaborators

  • Zheng Guo

    lead OTHER

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2023-09-30
Completion
2023-10-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05344794 on ClinicalTrials.gov